Diet Restriction for Behcet's Disease with Tinnitus in Obesity

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study assigns 40 adults with Behcet’s disease, obesity, and bilateral tinnitus to either an immediate low-calorie diet group or a waitlist control. The intervention lasts 12 weeks, focusing on dietary restriction to see if weight loss or metabolic changes influence tinnitus symptoms. Researchers will compare outcomes between the diet group and the waitlist group to gauge potential benefits. The study is conducted at Cairo University and aims to clarify whether dietary modification can address a comorbidity that includes tinnitus in this population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* behcet disease
* obesity
* subjective tinnitus (bilateral)

Exclusion Criteria:

* other autoimune diseases
* refusal to participate

Where it's running

• Cairo University
  Giza, Dokki, Egypt Recruiting
• Cairo University
  Dokki, Giza Governorate, Egypt Recruiting

Study contacts

• Principal investigator: Ali MA Ismail, lecturer — Cairo University
• Study coordinator: Ali MA Ismail, lecturer
• Email: ali.mohamed@pt.cu.edu.eg
• Phone: 01005154209

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• Ocular Changes in People Using Tirzepatide or Semaglutide

  This study checks whether eye structure and blood vessels change in adults with obesity who are taking semaglutide or tirzepatide as part of routine care.

  Recruiting Istanbul University · Istanbul, Istanbul · NCT07924618

• Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes

  This study tests whether eight weeks of supervised whole-body vibration training changes ankle muscle activity and walking performance in women with obesity, comparing those with and without type 2 diabetes.

  Recruiting Pamukkale University · Denizli · NCT07924436

• Berobenatide for knee pain in adults who are overweight or with obesity

  This study tests berobenatide vs. placebo to see if it reduces knee pain and improves function while helping with weight in adults with knee osteoarthritis and overweight/obesity.

  Recruiting at 7 sites Phase 3 Pfizer · Tempe, Arizona and 39 other locations · NCT07919678

• Weekly berobenatide for knee osteoarthritis in adults who are overweight or obese

  This study tests whether weekly berobenatide helps reduce knee pain and improve function, while also affecting body weight, in adults with knee osteoarthritis who are overweight or obese (with or without type 2 diabetes).

  Recruiting Phase 3 Pfizer · Birmingham, Alabama and 3 other locations · NCT07915609

• Maridebart cafraglutide in people who switched from weekly GLP-1 receptor agonists

  This study tests how much maridebart cafraglutide appears in the blood after people with overweight or obesity switch from weekly GLP-1 receptor agonists.

  Recruiting at 9 sites Phase 1 Amgen · Phoenix, Arizona and 8 other locations · NCT07908316

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.